Us Bancorp \De\ Adicet Bio, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$5.52 - $9.23 $2,185 - $3,655	396 Added 32.38%	1,619 $9,000
Q4 2022 Feb 13, 2023	BUY	$7.72 - $21.27 $8,237 - $22,695	1,067 Added 683.97%	1,223 $10,000
Q3 2022 Oct 27, 2022	BUY	$13.43 - $18.74 $2,095 - $2,923	156 New	156 $2,000
Q2 2022 Aug 01, 2022	SELL	$10.26 - $20.81 $790 - $1,602	-77 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$11.53 - $19.97 $887 - $1,537	77 New	77 $2,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.